China's healthcare sector is making steady progress in opening up to foreign investment and expertise, with more than 150 joint-venture and wholly overseas-invested medical institutions now operating nationwide, a senior health official announced Monday.

The 2024 annual reports of major Chinese IVD companies released.

NEW YORK (GenomeWeb) Agilent Technologies announced today that it has agreed to acquire ACEA Biosciences for $250 million in cash. Privately held ACEA, which is based in San Diego, has most recently developed a line of xCELLigence impedance-

Rady Childrens Hospital San Diego said recently that it is launching a pilot project, funded with $2 million from the California Medical Assistance Program (Medi-Cal), to offer rapid whole-genome sequencing for critically ill newborns. The

Recently, Brooks Automation, Inc. announced the acquisition of GENEWIZ, the worlds leading provider of genomic services. The total purchase price of the purchase will be approximately $450 million, requiring working capital and other adjust

Pennsylvania-based JBS Science said recentlythat it has received a $3 million Small Business Innovation Research Phase IIB Bridge Award from the National Cancer Institute to help commercialize its first liquid biopsy product, a urine DNA scr

Recently, leading molecular diagnostic data analysis startup Tempus announced the completion of E round of financing, with a total financing of 110 million dollars. This is Tempus third financing in 11 months. After this round of financing,

Premaitha Health said recentlythat it has settled its patent dispute and signed a licensing and supply agreement with Illumina related to noninvasive prenatal testing technology. Under the agreement, Manchester, UK-based Premaitha has licens

Quadrant Biosciences said recentlythat it hasreceived a $2 million grant from the National Institutes of Health to finalize development of a saliva-based diagnostic for autism spectrum disorder(ASD). According to Syracuse, New York-based Qua

Agendia recentlyannounced a partnership with GeneCast Biotechnology to make its breast cancer tests available in China. Under the terms of the deal, Beijing-based GeneCast has the exclusive right to market Agendias MammaPrint and BluePrint t

Early treatment ofautism spectrum disorder(ASD) can significantly improve the lives of affected children and their families, but diagnosing the disorder is often a challenge. A company in Syracuse, NY hasdeveloped an epigenetic test that cou

Researchers from Aromyx Corp. announced this month that the companys flagship technology, the EssenceChip, will be made available to select partners by the end of this year. The new biosensor technology was designed to work with a digital pl